Xin Meng

Title: Innovations and Contributions of Inventor Xin Meng

Introduction: Xin Meng is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cyclin-dependent kinase (CDK) inhibitors. With a total of five patents to his name, his work has the potential to impact the treatment of various diseases.

Latest Patents: Xin Meng's latest patents include two notable inventions. The first is titled "2,4-disubstituted pyrimidines as CDK inhibitors." This patent discloses a 2,4-disubstituted pyrimidine derivative and its use as a therapeutically effective CDK inhibitor. Specifically, it focuses on a new derivative that acts as a selective CDK4/6 inhibitor, which can be utilized in preventing or treating diseases related to CDK4/6. The second patent is "Heterocyclic-substituted pyridinopyrimidinone derivative as CDK inhibitor and use thereof." This invention relates to a heterocyclic-substituted pyridinopyrimidinone derivative, also serving as a therapeutically effective CDK inhibitor, with applications in treating diseases associated with CDK4/6.

Career Highlights: Throughout his career, Xin Meng has worked with notable companies such as NEC (China) Co., Ltd. and Shanghai Xunhe Pharmaceutical Technology Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations: Xin Meng has collaborated with several professionals in his field, including Yongyong Zheng and Hua Jin. These collaborations have likely enhanced his research and development efforts in creating effective pharmaceutical solutions.

Conclusion: Xin Meng's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work in developing CDK inhibitors showcases the potential for advancements in medical treatments.